Calliditas Therapeutics Ab logo

Calliditas Therapeutics Ab Share Price Today (NASDAQ: CALT)

Calliditas Therapeutics Ab share price is $0 & ₹0.00 as on 19 Sep 2024 IST

▲

-40

(-100%)

Live

Bell Icon

The stock has been delisted from the stock exchange on 20 Sep 2024

View live Calliditas Therapeutics Ab share price in Dollar and Rupees. Guide to invest in Calliditas Therapeutics Ab stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Calliditas Therapeutics Ab, along with analyst recommendations, forecasts, and comprehensive financials.

Calliditas Therapeutics Ab (CALT) Key Statistics

in dollars & INR

Previous Close
$40.0001
Open
$40.0
Market Capitalization
$1.1B
Today's Volume
$9.8K
Revenue TTM
$1.6B
EBITDA
$-365.4M
Earnings Per Share (EPS)
$-1.75
Profit Margin
-30.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-157.2%

How to invest in Calliditas Therapeutics Ab Stock (CALT) from India?

It is very easy for Indian residents to invest directly in Calliditas Therapeutics Ab from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Calliditas Therapeutics Ab stock in both Indian Rupees (INR) and US Dollars (USD). Search for Calliditas Therapeutics Ab or CALT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Calliditas Therapeutics Ab or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Calliditas Therapeutics Ab shares which would translate to null fractional shares of Calliditas Therapeutics Ab as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Calliditas Therapeutics Ab, in just a few clicks!

Global Institutional Holdings in Calliditas Therapeutics Ab

  • Bvf Inc

    2.78%

  • Ironwood Investment Management LLC

    0.09%

  • Optiver Holding B.V.

    0.08%

  • UBS Group AG

    0.04%

  • Penderfund Capital Management Ltd

    0.02%

  • Susquehanna International Group, LLP

    0.02%

Analyst Recommendation on Calliditas Therapeutics Ab

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Calliditas Therapeutics Ab(by analysts ranked 0 to 5 stars)

About Calliditas Therapeutics Ab

Calliditas Therapeutics AB (publ), a commercial-stage bio-pharmaceutical company, focused on identifying, developing, and commercializing novel treatments in orphan indications with an initial focus on renal and hepatic diseases with significant unmet medical needs in the United States, Europe, and Asia. It offers Nefecon (TARPEYO/Kinpeygo), an oral formulation of budesonide to reduce the loss of kidney function in adults with immunoglobulin A nephropathy. The company's lead compound is Setanaxib, a NOX inhibitor that is in Phase 2b clinical trial for the treatment of primary biliary cholangitis; and in Phase 2 clinical trial for the treatment of squamous cell carcinoma of the head and neck cancer and idiopathic pulmonary fibrosis, as well as for solid tumors and Alport Syndrome. Calliditas Therapeutics AB (publ) was incorporated in 2004 and is headquartered in Stockholm, Sweden. As of September 13, 2024, Calliditas Therapeutics AB (publ) operates as a subsidiary of Asahi Kasei Corporation.
Organization
Calliditas Therapeutics Ab
Employees
222
CEO
Ms. Renee Aguiar-Lucander
Industry
Health Technology

Important FAQs about investing in CALT Stock from India :

Can Indians buy Calliditas Therapeutics Ab shares?

Yes, Indians can invest in the Calliditas Therapeutics Ab (CALT) from India.

With INDmoney, you can buy Calliditas Therapeutics Ab at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Calliditas Therapeutics Ab at zero transaction cost.

How can I buy Calliditas Therapeutics Ab shares from India?

It is very easy to buy Calliditas Therapeutics Ab from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Calliditas Therapeutics Ab (CALT) be purchased?

Yes, you can buy fractional shares of Calliditas Therapeutics Ab with INDmoney app.

What are the documents required to start investing in Calliditas Therapeutics Ab stocks?

To start investing in Calliditas Therapeutics Ab, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Calliditas Therapeutics Ab?

Today's market capitalisation of Calliditas Therapeutics Ab CALT is 1.1B

Who is the Chief Executive Officer (CEO) of Calliditas Therapeutics Ab ?

Ms. Renee Aguiar-Lucander is the current Chief Executive Officer (CEO) of Calliditas Therapeutics Ab.